The most recent insider trading activity for Amazon Biotech Inc. occurred on May 2, 2005. Chief Technology Officer Chaim Justman executed multiple sell transactions during the spring of 2005. Prior to these, Secretary/Treasurer Michael Vardakis sold a significant volume of shares in February 2004. No insider trading activity has been reported in the last three months.